Precigen, Inc. balance sheet

At the end of fiscal 2025, Precigen, Inc. had total assets of $156m, total liabilities of $135m and shareholders' equity of $20.9m. It held $30.2m in cash against $100m of debt: net debt of $69.8m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Precigen, Inc.: balance sheet, annual
Fiscal year	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	20	10	50	27	136	63	68	97	66	52	36	5	8	30	30
Receivables	—	0	1	15	25	22	20	21	21	16	1	1	1	1	4
Total current assets	—	14	188	175	324	315	154	285	235	149	157	118	69	102	115
Goodwill	—	0	14	101	165	157	94	94	54	54	38	37	27	19	15
Total assets	—	152	469	576	982	949	847	716	456	315	360	216	151	145	156
Accounts payable	—	1	1	6	5	8	9	12	6	5	3	4	2	4	12
Deferred revenue (current)	—	10	8	17	35	53	43	11	6	3	1	0	1	1	1
Total current liabilities	—	17	20	47	76	95	80	62	123	42	35	79	23	22	37
Short-term debt	—	—	0	2	1	0	1	0	32	0	0	43	0	—	—
Long-term debt	—	—	2	9	8	8	8	211	186	172	180	0	—	0	93
Total debt	0	0	2	13	9	9	8	212	220	204	203	86	0	0	100
Total liabilities	—	67	88	167	277	380	300	337	384	247	253	90	33	79	135
Shareholders' equity	−221	−322	367	385	694	560	534	363	72	67	107	126	118	39	21
Non-controlling interests and other (assets − liabilities − equity)	—	407	15	25	—	—	—	16	—	—	—	—	—	28	—
Net debt (negative = net cash)	−20	−10	−48	−15	−127	−54	−60	115	154	152	167	82	−8	−30	70
Shares outstanding	—	6m	—	101m	117m	119m	122m	160m	163m	188m	207m	208m	249m	293m	354m

US$ millions unless shown otherwise. Fiscal quarters.

Precigen, Inc.: balance sheet, quarterly
Quarter	2022 Q3Sept 2022	2022 Q4Dec 2022	2023 Q1Mar 2023	2023 Q2Jun 2023	2025 Q1Mar 2025	2025 Q2Jun 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	1	1	2	1	1	0	26	72
Total current assets	163	118	138	106	85	63	102	134
Goodwill	37	37	37	37	19	15	15	15
Total assets	259	216	242	208	129	102	139	170
Accounts payable	4	4	4	3	3	4	3	5
Deferred revenue (current)	0	0	0	0	1	0	0	0
Total current liabilities	105	79	47	31	24	23	21	29
Short-term debt	82	43	14	0	—	—	—	—
Long-term debt	0	0	—	—	—	—	94	94
Total debt	82	43	14	0	—	—	94	94
Total liabilities	117	90	57	41	113	108	118	127
Shareholders' equity	143	126	184	166	−14	−37	20	44
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	30	31	—	—
Shares outstanding	208m	208m	255m	255m	295m	298m	356m	358m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: JANX vs PGEN CRSP vs PGEN PGEN vs SCYX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Precigen, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Precigen, Inc.